Communication gaps between patients with breast cancer, caregivers, oncology care team
the ONA take:
Survey results presented at the 37th Annual San Antonio Breast Cancer Symposium reveal that discussions on basic disease information between patients with metastatic breast cancer, their caregivers, and oncologists need improvement.
The “Make your dialogue count” survey was conducted from June 2014 through August 2014. It was developed to gain insight from adult women ages 21 years and older with metastatic breast cancer, adult caregivers of these patients who attend at least half the patients’ clinic visits, and medical oncologists who treat five or more women with metastatic breast cancer per month.
Survey results indicate most patients (83%) and caregivers (76%) are extremely or very involved in treatment decisions; however, many patients and caregivers did not know the HER2 status (20% and 29%, respectively) or the HR status (16% and 30%, respectively).
In addition, 27% of oncologists indicated that they do not discuss the fact that metastatic breast cancer is incurable with patients in certain circumstances.
Most patients (73%) want more information on preventing and minimizing side effects; however, 43% of patients do not always openly discuss side effects with their oncologists. The investigators conclude that improved dialogue can clarify patients’ and caregivers’ expectations about disease management.
Discussions on basic disease information between patients with metastatic breast cancer, caregivers, and oncologists.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
- Exercise May Mitigate Cardiotoxicity Associated With Doxorubicin Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|